Use of high resolution LC-MSn analysis in conjunction with mechanism-based stress studies: Identification of asarinin, an impurity from sesame oil in an animal health product

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 1015-1021

  Wang, Xin ^a   Peng, Yanan ^a   Li, Min ^a   Rustum, Abu M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Asarinin; Forced degradation; LC MS; Sesamin; Stress study

Indexed keywords

ASARININ; EXCIPIENT; SESAME SEED OIL; SESAMIN;

ACCURACY; ACIDITY; ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG QUALITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; MECHANICAL STRESS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIOXOLES; DRUG CONTAMINATION; DRUG STABILITY; IONS; LIGNANS; PHARMACEUTICAL PREPARATIONS; SESAME OIL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNOLOGY, PHARMACEUTICAL; VETERINARY DRUGS;

EID: 70349165074     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.05.041     Document Type: Article

References (8)

1. ICH Harmonised Tripartitie Guideline, Impurities in New Drug Substances, Q3A(R2), Current Step 4 version, dated 25 October 2006.
2. ICH Harmonised Tripartitie Guideline, Impurities in New Drug Products, Q3B(R2), Current Step 4 version, dated 2 June 2006.
3. VICH GL11 (#93) Guidance for Industry: Impurities in New Veterinary Medicinal Products, Revised at Step 9, dated September 2007.
4. Lee M.S. LC/MS Applications in Drug Development (2002), Wiley, New York
5. Jiang H., Somogyi A., Timmermann B.N., and Gang D.R. Rapid Commun. Mass Spectrom. 20 (2006) 3089-3100
6. Li M., Chen B., Lin M., and Rustum A. Am. Pharm. Rev. 11 1-2 (2008) 98-103
7. Li M., Lin M., and Rustum A. J. Pharm. Biomed. Anal. 48 (2008) 1451-1456
8. Li C.-Y., Chow T.J., and Wu T.-S. J. Nat. Prod. 68 (2005) 1622-1624